Masimo Corp (MASI)

The most recent short interest data has been released for the 06/30/2017 settlement date, which shows a 396,166 share increase in total short interest for Masimo Corp. , to 2,825,251, an increase of 16.31% since 06/15/2017.

Masimo (NASDAQ: MASI) announced today the CE marking of the rainbow ® Super DCI ®-mini sensor, a reusable spot-check sensor that features Masimo SET ® Measure-through Motion and Low Perfusion™...

Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at Euroanaesthesia 2017 in Geneva, Switzerland.

Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at the recent International Anesthesia Research Society (IARS) Annual Meeting in Washington, DC.

Masimo (NASDAQ:MASI) announced today, in conjunction with its CE marking, the limited market release of the Spot-Check Rad-67™ Handheld Pulse CO-Oximeter ®.

Masimo (NASDAQ: MASI) and Mdoloris Medical Systems announced today a Masimo Open Connect™ (MOC) partnership for the Root ® Open Architecture Patient Monitoring and Connectivity Hub, in which Mdoloris is...

Masimo (NASDAQ:MASI) announced today FDA 510(k) clearance for the pediatric indication for O3™ regional oximetry with the O3 pediatric sensor.

The most recent short interest data has been released for the 05/15/2017 settlement date, which shows a 765,702 share decrease in total short interest for Masimo Corp. , to 2,329,761, a decrease of 24.74% since 04/28/2017.

Masimo (NASDAQ: MASI) announced today the full market release of Early Warning Score (EWS) on the Root ® patient monitoring and connectivity hub.

Midmark Corporation, a leading medical solutions provider for ambulatory care, and Masimo (NASDAQ: MASI), a global leader in innovative noninvasive monitoring technologies, today announced a partnership focused on improving...

Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at the International Anesthesia Research Society (IARS) Annual Meeting in Washington, DC.

Joe Kiani, founder, chairman and CEO of Masimo, tells Jim Cramer about his company's great earnings.

Jim Cramer lays out next week's game plan: Tech stocks look strong, but same-store sales are sinking retail.

Masimo (NASDAQ:MASI) today announced the introduction of Rad-G™, a combined pulse oximeter designed primarily for use in pneumonia screening and spot-checking of oxygen saturation (SpO 2) in low-resource...

Finding bullish and bearish reversals in the market.

Masimo (NASDAQ: MASI) today announced its financial results for the first quarter ended April 1, 2017.

Masimo (NASDAQ: MASI) announced today that it will release financial results for the first quarter ended April 1, 2017, after the market closes on Wednesday, May 3, 2017.

Masimo (NASDAQ: MASI) announced today that the Congressional Fire Services Institute (CFSI) has honored the Orange County (Florida) Fire Rescue Department and the Montgomery County (Maryland) Fire & Rescue...

Masimo (NASDAQ:MASI) announced today the full market release of Root ® with Kite™, a supplemental display system.

Jim Cramer is bullish on Nucor, Canada Goose, Masimo, Scotts Miracle-Gro.

Rebounding markets and earnings prove this market is about much more than Trump's political miasma.

Masimo (NASDAQ: MASI) announced today that Massena Memorial Hospital (MMH) of Massena, New York, has adopted Masimo Root ® and Patient SafetyNet™*.

Masimo (NASDAQ: MASI) announced today the CE marking of noninvasive blood pressure (NIBP) measurements for the Rad-97™ Pulse CO-Oximeter ® and connectivity hub.

Masimo (NASDAQ:MASI) announced today the publication of a recent study conducted on adult patients undergoing liver transplantation (LT), in which researchers assessed the accuracy and trending ability of noninvasive...

Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the 29th Annual ROTH Conference at the Ritz Carlton Laguna Niguel on Tuesday, March 14, 2017 at 10:30 a.

Masimo (NASDAQ: MASI) announced today availability of the RD SedLine ® EEG sensor, for use with Masimo SedLine Brain Function Monitoring and compatible with simultaneous use of Masimo O3™ Regional Oximetry.

This patient-monitoring device-maker has plenty of room for growth.

Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the 38th Annual Raymond James Institutional Investors Conference at the Marriott Grande Lakes in Orlando on Tuesday, March 7, 2017...